About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Aug 08, 2023...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, operate in stealth and cannot be targeted by the body’s regular immune system.
Edity Therapeutics, an Israeli startup founded in 2019, reprograms a patient’s own immune cells, giving them the ability to hunt down and destroy these cancer cells. It’s like transforming regular beat cops into lethal supersleuths.
Aug 08, 2023... Israeli study finds biological treatment effective for lung cancer
Jan 18, 2024... REHOVOT, ISRAEL—January 18, 2024—Winning a battle requires precise intelligence and unwavering resolve. But when it comes to the battle against cancer, the immune system’s soldiers – called T cells – quickly become exhausted, and intelligence-providing dendritic cells are scarce. This is one of the reasons why the great promise of immunotherapy – a new generation of treatments that harness the body’s own immune system to fight cancer – has not been fully realized.